Molecular targets in cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Cell Line HCT116 Cells Cells, Cultured Breast HT29 Cells Prostate Epithelial Cells MCF-7 Cells

Organisms6

Mice, Nude Mice, SCID Mice, Inbred C57BL Mice, Inbred BALB C Mice, Transgenic Mice, Knockout

Diseases44

Prostatic Neoplasms Neoplasms Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Colonic Neoplasms Neoplasm Invasiveness Stomach Neoplasms Neoplasm Metastasis Pancreatic Neoplasms Disease Progression Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Genetic Predisposition to Disease Carcinoma Uterine Cervical Neoplasms Colorectal Neoplasms Cell Transformation, Neoplastic Urinary Bladder Neoplasms Neovascularization, Pathologic Rectal Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Liver Neoplasms Endometrial Neoplasms Head and Neck Neoplasms Neoplasms, Hormone-Dependent Esophageal Neoplasms Mouth Neoplasms Disease Models, Animal Gastrointestinal Neoplasms Skin Neoplasms Melanoma Carcinoma, Small Cell Neoplasms, Radiation-Induced Thyroid Neoplasms Bone Neoplasms Neoplasms, Second Primary Mammary Neoplasms, Experimental Neoplasms, Glandular and Epithelial Kidney Neoplasms Genital Neoplasms, Female Precancerous Conditions Neoplasms, Experimental

Chemicals and Drugs67

Antineoplastic Agents Neoplasm Proteins RNA, Small Interfering RNA, Messenger Cancer Vaccines Tumor Markers, Biological Anticarcinogenic Agents Receptor, erbB-2 Receptors, Estrogen Tumor Suppressor Protein p53 Antineoplastic Agents, Phytogenic Protein Kinase Inhibitors DNA, Neoplasm Enzyme Inhibitors Receptor, Epidermal Growth Factor Transcription Factors Prostate-Specific Antigen DNA-Binding Proteins Antibodies, Monoclonal Antigens, Neoplasm MicroRNAs Receptors, Progesterone Tumor Suppressor Proteins Cisplatin Proto-Oncogene Proteins c-akt Fluorouracil Tamoxifen Paclitaxel Protein-Serine-Threonine Kinases Antineoplastic Agents, Hormonal Nuclear Proteins Proto-Oncogene Proteins RNA, Neoplasm NF-kappa B DNA Primers Membrane Proteins Catechin Carcinogens Taxoids beta Catenin Quinazolines Antibodies, Monoclonal, Humanized Cyclooxygenase 2 Indoles Estrogens TOR Serine-Threonine Kinases Deoxycytidine Curcumin Proto-Oncogene Proteins c-bcl-2 Small Molecule Libraries Cell Cycle Proteins Carrier Proteins Antibiotics, Antineoplastic Estrogen Receptor alpha Stilbenes Antimetabolites, Antineoplastic Vascular Endothelial Growth Factor A Receptors, Androgen Phosphatidylinositol 3-Kinases Inhibitor of Apoptosis Proteins Tea ras Proteins Polyphenols BRCA2 Protein Plant Extracts Apoptosis Regulatory Proteins Radiation-Sensitizing Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Early Detection of Cancer Molecular Targeted Therapy Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Blotting, Western Prognosis Drug Screening Assays, Antitumor Survival Analysis Oligonucleotide Array Sequence Analysis Antineoplastic Combined Chemotherapy Protocols Survival Rate Neoplasm Transplantation Drug Delivery Systems Neoplasm Staging Risk Clinical Trials as Topic Follow-Up Studies Transfection Retrospective Studies Models, Biological Registries Transplantation, Heterologous Prospective Studies Combined Modality Therapy Drug Design Disease-Free Survival Risk Assessment Gene Knockdown Techniques Polymerase Chain Reaction Odds Ratio Sensitivity and Specificity Immunohistochemistry Tumor Burden Chemotherapy, Adjuvant Chemoprevention Kaplan-Meier Estimate Disease Models, Animal Tissue Array Analysis Flow Cytometry Mammography Multivariate Analysis Risk Factors Reproducibility of Results Questionnaires SEER Program Predictive Value of Tests Immunoenzyme Techniques Real-Time Polymerase Chain Reaction Genetic Therapy Drug Evaluation, Preclinical Mammary Neoplasms, Experimental Inhibitory Concentration 50 Immunotherapy Drug Discovery Logistic Models Treatment Outcome Radiotherapy Individualized Medicine Neoplasm Grading Confidence Intervals Cluster Analysis Neoplasms, Experimental Immunoblotting DNA Mutational Analysis Incidence Drug Administration Schedule Positron-Emission Tomography In Situ Hybridization, Fluorescence

Psychiatry and Psychology1

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Apoptosis Signal Transduction Drug Resistance, Neoplasm Cell Proliferation Mutation Genetic Predisposition to Disease Cell Survival Down-Regulation Dose-Response Relationship, Drug Cell Cycle Risk Cell Movement Transfection Cell Growth Processes RNA Interference Cell Division Up-Regulation Phosphorylation DNA Methylation Promoter Regions, Genetic Gene Silencing Gene Expression Odds Ratio Sensitivity and Specificity Genotype Base Sequence Protein Binding Genes, Tumor Suppressor Genes, Neoplasm Phenotype Genes, BRCA1 Transcription, Genetic Diet Polymorphism, Genetic Amino Acid Sequence Enzyme Activation Inhibitory Concentration 50 Drug Synergism DNA Damage Time Factors Germ-Line Mutation Epigenesis, Genetic Gene Expression Regulation Cell Death Genes, p53 Postmenopause Genes, BRCA2 Binding Sites MAP Kinase Signaling System

Disciplines and Occupations6

Drug Design Medical Oncology Immunohistochemistry Proteomics Drug Discovery Individualized Medicine

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture1

Humanities2

Literature, Modern Quality of Life

Information Science8

Survival Rate Registries Molecular Sequence Data Base Sequence Questionnaires SEER Program Amino Acid Sequence Incidence

Named Groups1

Health Care27

Survival Analysis Survival Rate National Cancer Institute (U.S.)Risk Clinical Trials as Topic Follow-Up Studies Retrospective Studies Registries Prospective Studies Disease-Free Survival Risk Assessment Odds Ratio Age Factors Sensitivity and Specificity Kaplan-Meier Estimate Multivariate Analysis Risk Factors Reproducibility of Results Questionnaires SEER Program Predictive Value of Tests American Cancer Society Logistic Models Treatment Outcome Confidence Intervals Cluster Analysis Incidence

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Early Detection of Cancer Prostatic Neoplasms Neoplasms Cell Line, Tumor Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Antineoplastic Agents Gene Expression Regulation, Neoplastic Mice, Nude Molecular Targeted Therapy Colonic Neoplasms Neoplasm Invasiveness Stomach Neoplasms Neoplasm Metastasis Neoplasm Proteins Pancreatic Neoplasms Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Apoptosis Signal Transduction Drug Resistance, Neoplasm RNA, Small Interfering RNA, Messenger Blotting, Western Cell Proliferation Mutation Cancer Vaccines Tumor Markers, Biological Prognosis Disease Progression Carcinoma, Squamous Cell Anticarcinogenic Agents Drug Screening Assays, Antitumor Survival Analysis Carcinoma, Non-Small-Cell Lung Genetic Predisposition to Disease Oligonucleotide Array Sequence Analysis Carcinoma Cell Survival Antineoplastic Combined Chemotherapy Protocols Uterine Cervical Neoplasms Colorectal Neoplasms Down-Regulation Receptor, erbB-2 Survival Rate Receptors, Estrogen Dose-Response Relationship, Drug Neoplasm Transplantation Cell Transformation, Neoplastic Drug Delivery Systems Cell Cycle Tumor Suppressor Protein p53 Urinary Bladder Neoplasms National Cancer Institute (U.S.)Neoplasm Staging Antineoplastic Agents, Phytogenic Risk Cell Movement Clinical Trials as Topic Follow-Up Studies Transfection Retrospective Studies Cell Growth Processes Neovascularization, Pathologic Protein Kinase Inhibitors Models, Biological Tumor Cells, Cultured Registries RNA Interference Transplantation, Heterologous Cell Division DNA, Neoplasm Up-Regulation United States Prospective Studies Molecular Sequence Data Combined Modality Therapy Drug Design Medical Oncology Enzyme Inhibitors Receptor, Epidermal Growth Factor Survivors Phosphorylation DNA Methylation Disease-Free Survival Risk Assessment Promoter Regions, Genetic Rectal Neoplasms Neoplasm Recurrence, Local Gene Knockdown Techniques Adenocarcinoma Gene Silencing Neoplastic Stem Cells Gene Expression Liver Neoplasms Transcription Factors Polymerase Chain Reaction Prostate-Specific Antigen

No FAQ available that match "molecular targets in cancer"